Summary
The Food and Drug Administration will not be given access to documents relating to the safety of drospirenone-containing oral contraceptives that pharmaceutical company Bayer has kept confidential in the Yaz and Yasmin multidistrict product liability litigation.
In a Nov. 10 order, U.S. District Court Judge David R. Herndon denied a request to lift a protective order regarding certain documents obtained from Bayer during the course of discovery in In re Yasmin and YAZ (Drospirenone) Marketing, Sales Practices and Products Liability Litigation.See the full content of this document
Extract
Yaz Plaintiff Loses Bid to Unseal Documents for Fda
The multidistrict litigation is in the Southern District of Illinois.
The plaintiffs' steering committee in the case wanted...See the full content of this document
Sponsored links
